Intelligence Hub
Market analytics and operational performance indicators
Insider Trading - June 23, 2025
Director Saintil sold 6,353 shares (~$187K) via 10b5-1 plan.
Brief
Merline Saintil, Director at Rocket Lab USA, sold 6,353 common shares on 06/20/2025 at weighted average prices of $28.75 and $29.65, leaving 425,922 shares directly owned. The transaction was automatic under a Rule 10b5-1 plan adopted on 03/20/2025. Neutral signal due to pre-scheduled nature.
Detailed Brief
Merline Saintil, a Director, reported selling 1,700 shares at a weighted average price of $28.7547 (range $28.03-$29.01) and 4,653 shares at $29.65 (range $29.08-$30.04) on June 20, 2025, pursuant to a Rule 10b5-1 trading plan established on March 20, 2025. Post-transaction, she beneficially owns 425,922 shares directly with no indirect ownership reported. This appears to be a routine execution of the pre-existing plan, with no indication of discretionary selling or unusual timing relative to earnings or announcements; total value approximately $187,000, representing about 1.5% of her prior direct holdings.
Key Telemetry
- • Sold 6,353 shares (1.5% of holdings), now owns 425,922 direct shares.
- • Executed under 10b5-1 plan from March 20, 2025 (standard scheduled sale).
- • Prices ~$29 (near recent highs, but pre-planned).
- • No pattern of recent sales or cluster activity noted.
Impact Vector
This pre-planned 10b5-1 sale signals neutral insider confidence, as it reflects automatic execution rather than discretionary action amid current market conditions.